For further details see:
Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022For further details see:
Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Outset Medical Inc. Company Name:
OM Stock Symbol:
Market:
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on ...
Agreement designed to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and com...
MONTREAL, April 16, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the " Company " or " Osisko Metals ") ( TSX-V: OM ; OTCQX: OMZNF ; FRANKFURT: 0B51 ) is pleased to announce preliminary metallurgical and grindability testwork results from the Gaspé Copp...